DURECT Corporation
US ˙ NasdaqCM ˙ US2666055007

Introduction

This page provides a comprehensive analysis of the known insider trading history of Dave Hoffmann. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Dave Hoffmann has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:DRRX / DURECT Corporation Director 55,000
US:MTEM / Molecular Templates, Inc. Director 15,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Dave Hoffmann. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases DRRX / DURECT Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in DRRX / DURECT Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2016-04-26 DRRX HOFFMANN DAVE 200,000 1.2500 20,000 12.5000 250,000 94 19.4 138,000 55.20
2012-05-10 DRRX HOFFMANN DAVE 300 0.7925 30 7.9250 238
2012-05-10 DRRX HOFFMANN DAVE 1,867 0.7950 187 7.9500 1,484
2012-05-10 DRRX HOFFMANN DAVE 300 0.7998 30 7.9980 240
2012-05-10 DRRX HOFFMANN DAVE 7,533 0.8000 753 8.0000 6,026
2012-05-10 DRRX HOFFMANN DAVE 200 0.7999 20 7.9990 160
2012-05-10 DRRX HOFFMANN DAVE 4,367 0.8000 437 8.0000 3,494
2012-05-10 DRRX HOFFMANN DAVE 300 0.8100 30 8.1000 243
2012-05-10 DRRX HOFFMANN DAVE 5,158 0.8200 516 8.2000 4,230
2012-05-10 DRRX HOFFMANN DAVE 4,600 0.8280 460 8.2800 3,809
2012-05-10 DRRX HOFFMANN DAVE 375 0.8300 38 8.3000 311

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRRX / DURECT Corporation Insider Trades
Insider Sales DRRX / DURECT Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in DRRX / DURECT Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

DRRX / DURECT Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Dave Hoffmann as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-06-16 2021-06-15 4 DRRX DURECT CORP
Stock Option (right to buy)
A - Award 55,000 55,000
2021-06-04 2021-06-03 4 MTEM Molecular Templates, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2020-06-18 2020-06-17 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2020-06-01 2020-05-28 4 MTEM Molecular Templates, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2019-06-20 2019-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2019-05-30 2019-05-29 4 MTEM Molecular Templates, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2018-06-20 2018-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2018-06-04 2018-05-31 4 MTEM Molecular Templates, Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2017-10-11 2017-10-09 4 MTEM Molecular Templates, Inc.
Stock Option (right to buy)
A - Award 25,000 25,000
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 0 -100.00
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Common Stock
M - Exercise 25,000 120,000 26.32 0.82 20,495 98,376
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Common Stock
M - Exercise 35,000 95,000 58.33 1.05 36,750 99,750
2017-09-21 2017-09-21 4 DRRX DURECT CORP
Common Stock
M - Exercise 35,000 60,000 140.00 1.19 41,650 71,400
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 39,151 94,151 71.18 1.06 41,500 99,800
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2016-06-28 2016-06-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 35,000 35,000
2016-06-23 2016-06-22 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2016-04-28 2016-04-26 4 DRRX DURECT CORP
Common Stock
P - Purchase 200,000 248,000 416.67 1.25 250,000 310,000
2016-04-04 2016-03-31 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 36,058 36,058 1.04 37,500 37,500
2015-07-06 2015-05-26 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20,000 20,000
2015-06-16 2015-06-15 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2015-03-30 2015-03-26 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 27,778 27,778
2014-06-17 2014-06-16 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2014-05-19 2014-05-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20,000 20,000
2014-04-01 2014-03-28 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 36,058 36,058
2013-06-26 2013-06-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2013-05-20 2013-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2013-02-07 2013-02-05 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 47,468 47,468
2012-06-21 2012-06-20 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 25,000 25,000
2012-05-21 2012-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Rigt to Buy)
A - Award 20,000 20,000
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 375 25,000 1.52 0.83 311 20,750
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 4,600 24,625 22.97 0.83 3,809 20,390
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 5,158 20,025 34.69 0.82 4,230 16,420
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 14,867 2.06 0.81 243 12,042
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 4,367 14,567 42.81 0.80 3,494 11,654
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 200 10,200 2.00 0.80 160 8,159
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 7,533 10,000 305.35 0.80 6,026 8,000
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 2,467 13.84 0.80 240 1,973
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 1,867 2,167 622.33 0.80 1,484 1,723
2012-05-14 2012-05-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 300 300 0.79 238 238
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)